EUCTR2012-001898-90-NL进行中（未招募）不适用
Effects of vernakalant and flecainide on atrial contractility in patients with atrial fibrillation - Vernakalant versus flecainide: atrial contractility
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- patients presenting with paroxysmal or persistent AF
- •- eligible for treatment with flecainide or vernakalant infusion to restore sinus rhythm
- •- receiving adequate anticoagulant therapy (or having an episode of AF lasting < 24 hours)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •- atrial flutter
- •- contra-indications for receiving flecainide or vernakalant infusion according to MUMC+ protocol (unstable hemodynamic condition, LVEF < 40%, inadequate potassium levels, acute ischaemia, sinus node dysfunction)
- •- age < 18 years
研究者
相似试验
尚未招募
4 期
Effects of vernakalant and flecainide on atrial contractility in patients with atrial fibrillatioatrial fibrillationNL-OMON37797Medisch Universitair Ziekenhuis Maastricht50
Unknown
4 期
Vernakalant Versus Flecainide: Atrial ContractilityAtrial FibrillationNCT01646281Maastricht University Medical Center70
尚未招募
不适用
A clinical trial to study the effects Flecainide on HV interval in patients with symptomatic Bifascicular blockCTRI/2020/12/029543King George Medical University
招募中
3 期
Effect of Colchicine on the Prevention of Atrial Fibrillation after Coronary Artery Bypass Grafting Surgery(CABG)Atrial Fibrillation.?????? ??? ??? ? ????I00-I99IRCT20220515054855N1Mazandaran University of Medical Sciences230
招募中
不适用
In-vivo Bioequivalence Test of Flecainide acetate tablets with brand drug (TAMBOCOR® 100 mg FC Tab, MEDA Pharmaceuticals LLC, USA)IRCT20200105046010N48Arena Hayat Danesh Pharmaceutical Company24